BioLife Solutions Net Current Debt 2010-2025 | BLFS

BioLife Solutions net current debt from 2010 to 2025. Net current debt can be defined as the net amount of debt repaid and issued with short-term maturities.

BioLife Solutions Net Current Debt 2010-2025 | BLFS

BioLife Solutions net current debt from 2010 to 2025. Net current debt can be defined as the net amount of debt repaid and issued with short-term maturities.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$228.8B
Boston Scientific (BSX)$156.9B
Stryker (SYK)$150.3B
EssilorLuxottica (ESLOY)$143.8B
Medtronic (MDT)$118.1B
Lonza Group Ag (LZAGY)$50B
Haleon (HLN)$43.5B
ResMed (RMD)$41.3B
GE HealthCare Technologies (GEHC)$33.9B
Agilent Technologies (A)$33.7B
Terumo (TRUMY)$26.9B
Koninklijke Philips (PHG)$26.7B
Insulet (PODD)$23.5B
Zimmer Biomet Holdings (ZBH)$21.2B
Smith & Nephew SNATS (SNN)$16.3B
Baxter (BAX)$12.6B
Sunny Optical Technology (SNPTF)$10.8B
Demant (WILYY)$8.1B
Bio-Rad Laboratories (BIO)$7.9B
Lantheus Holdings (LNTH)$3.9B
Envista Holdings (NVST)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Prestige Consumer Healthcare (PBH)$3.3B
Perrigo (PRGO)$3.3B
ICU Medical (ICUI)$3.1B
Haemonetics (HAE)$2.7B
LeMaitre Vascular (LMAT)$2.2B
Curaleaf Holdings (CURLF)$2.1B
Acuren (TIC)$2.1B
QuidelOrtho (QDEL)$1.9B